96
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Serum levels of the extracellular domain of the epidermal growth factor receptor in individuals exposed to arsenic in drinking water in Bangladesh

, , , , , & show all
Pages 256-265 | Received 16 May 2006, Published online: 08 Oct 2008

References

  • Ahsan H, Chen Y, Parvez F, Argos M, Hussain AI, Momotaj H, Levy D, van Geen A, Howe G, Graziano J. Health effects of arsenic longitudinal study (HEALS): description of a multidisciplinary epidemiologic investigation. Journal of Exposure Science and Environmental Epidemiology 2006; 16: 191–205
  • Brandt-Rauf PW. The c-erbB transmembrane growth factor receptors as serum biomarkers in human cancer studies. Mutation Research 1995; 333: 203–208
  • Cheng Z, Zheng Y, Mortlock R, van Geen A. Rapid multi-element analysis of groundwater by high-resolution inductively coupled plasma mass spectrometry. Analytical and Bioanalytical Chemistry 2004; 379: 512–518
  • Choi JH, Oh JY, Ryu SK, Kim SJ, Lee NY, Kim YS, Yi SY, Shim KS, Han WS. Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients. Cancer 2000; 79: 1879–1883
  • Do T, Gambelunghe A, Ahsan H, Graziano J, Perrin M, Slavkovic V, Parvez F, Milton AH, Brandt-Rauf P. Urinary transforming growth factor-alpha in individuals exposed to arsenic in drinking water in Bangladesh. Biomarkers 2001; 6: 127–132
  • Faux SP, Houghton CE, Hubbard A, Patrick G. Increased expression of epidermal growth factor receptor in rat pleural mesothelial cells correlates with carcinogenicity of mineral fibres. Carcinogenesis 21:2275–2280.
  • Germolec DR, Spalding J, Yu HS, Chen GS, Simeonova PP, Humble MC, Bruccoleri A, Boorman GA, Foley JF, Yoshida T, Luster MI. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. American Journal of Pathlogy 1998; 153: 1775–1785
  • Gordon-Thomas C, Jones J, Mason RS, Moore GP. ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells. Melanoma Research 2005; 15: 21–28
  • Hemminki K, Palmgren J, Korhonen P, Partanen R, Brandt-Rauf P, Rautalahti M, Albanes D, Virtamo J. Serum epidermal growth factor receptor and p53 as predictors of lung cancer risk in the ATBC study. Biomarkers 1999; 4: 72–84
  • Hsu K-H, Brandt-Rauf P, Lin T-M, Chiou H-Y, Tseng C-H, Chen C-J, Luo J-CJ. Plasma-transforming growth factor-alpha expression in residents of an arseniasis area of Taiwan. Biomarkers 2006; 6: 538–546
  • MacDonald R. Providing clean water: lessons from Bangladesh. British Medical Journal 2001; 322: 626–627
  • McCulloch RK, Walker CE, Chakera A, Jazayeri J, Leedman PJ. Regulation of EGF-receptor expression by EGF and TGF alpha in epidermoid cancer cells is cell type-specific. International Journal of Biochemistry and Cell Biology 1998; 30: 1265–1278
  • Nixon DE, Mussmann GV, Eckdahl SJ, Moyer TP. Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clinical Chemistry 1991; 37: 1575–1579
  • Nriagu JO. Arsenic in the Environment. II. Human Health and Ecosystems Effects. Wiley and Sons, New York 1994
  • Oh MJ, Choi JH, Kim IH, Lee YH, Huh JY, Park YK, Lee KW, Chough SY, Joo KS, Ku BS, Saw HS. Detection of epidermal growth factor receptor in the serum of patients with cervical carcinoma. Clinical Cancer Research 2000; 6: 4760–4763
  • Partanen R, Hemminki K, Koskinen H, Luo JC, Carney WP, Brandt-Rauf PW. The detection of increased amounts of the extracellular domain of the epidermal growth factor receptor in asbestosis patients. Journal of Occupational Medicine 1994a; 36: 1324–1328
  • Partanen R, Hemminki K, Brandt-Rauf P, Jin CG, Koskinen H. Serum levels of growth factor receptors, EGFR and Neu in asbestosis patients: a follow-up study. International Journal of Oncology 1994b; 4: 1025–1028
  • Partanen R, Koskinen H, Oksa P, Hemminki K, Carney W, Smith S, Brandt-Rauf PW. Serum oncoproteins in asbestosis patients. Clinical Chemistry 1995; 41: 1844–1847
  • Smith AH, Lingas EO, Rahman M. Contamination of drinking water by arsenic in Bangladesh: a public health emergency. Bulletin of the World Health Organization 2000; 78: 1093–1103
  • Styblo M, Drobna Z, Jaspers I, Lin S, Thomas DJ. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environmental Health Perspectives 2002; 110: 767–771
  • Tapio S, Grosche B. Arsenic in the aetiology of cancer. Mutation Research 2006; 612: 215–246
  • van Geen A, Ahsan H, Horneman AH, Dhar RK, Zheng Y, Hussain I, Ahmed KM, Gelman A, Stute M, Simpson HJ, Wallace S, Small C, Parvez F, Slavkovich V, Loiacono NJ, Becker M, Cheng Z, Momotaj H, Shahnewaz M, Seddique AA, Graziano JH. Promotion of well-switching to mitigate the current arsenic crisis in Bangladesh. Bulletin of the World Health Organization 2002; 80: 732–737
  • van Geen A, Zheng Y, Versteeg R, Stute M, Horneman A, Dhar R, Steckler M, Gelman A, Small C, Ahsan H, Graziano JH, Hussain I, Ahmed KM. Spatial variability of arsenic in 6000 tube wells in a 25 km2 area of Bangladesh. Water Resources Research 2003; 39: 1140–1150
  • Vela NP, Heitkemper DT. Total arsenic determination and speciation in infant food products by ion chromatography-inductively coupled plasma-mass spectrometry. Journal of AOAC International 2004; 87: 244–252

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.